Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2022-001105-40Phase 2Completed
Phase 2, randomised trial in postoperative hemorrhage and cardiac disease comparing RIASTAP with FIBRICLOTTE (2 arms). Primary endpoint: Clot firmness and clot formation parameters. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2022-001105-40.